Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,002 | 158,874 | N/A | N/A | N/A |
| Marketable Securities | 169,815 | N/A | N/A | N/A | N/A |
| Other current assets | 10,961 | 6,745 | 0 | 0 | 0 |
| TOTAL | $317,183 | $165,775 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,795 | 1,087 | N/A | N/A | N/A |
| Other Non-Current Assets | 8,029 | 11,751 | 0 | 0 | 0 |
| TOTAL | $10,824 | $12,838 | $N/A | $N/A | $N/A |
| Total Assets | $328,007 | $178,613 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,265 | 629 | 0 | 0 | 0 |
| Accrued Expenses | 15,910 | 3,052 | N/A | N/A | N/A |
| TOTAL | $21,175 | $3,681 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 41 | 230,681 | 0 | 0 | 0 |
| TOTAL | $2,118 | $231,185 | $N/A | $N/A | $N/A |
| Total Liabilities | $23,293 | $234,866 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,692 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | N/A | N/A |
| Retained earnings | -170,895 | -58,663 | N/A | N/A | N/A |
| Other shareholders' equity | -12 | 0 | 0 | 0 | 0 |
| TOTAL | $304,714 | $-56,253 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $328,007 | $178,613 | $0 | $0 | $0 |